Cynata Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WACynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology.
Cynata's product candidate CYP-001 met all clinical endpoints and demonstrated positive safety and efficacy data for the treatment of steroid-resistant acute graft-versus-host disease (GvHD) in a Phase 1 trial.
Contact Details
Level 3, 62 Lygon Street, CARLTON VIC 3053
03 9824 5254
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 963rd |  | Cynata Therapeutics | $1.7m |
| 1156th | | Carbon Minerals | $32k |
| 1158th | | Talon Energy | $29k |
| 1160th | | Sky Metals | $27k |
| 1161st | | Sportshero | $25k |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 942nd | Sky Metals | -14% | 61% |
| 1138th | Sportshero | -28% | -29% |
| 1292nd | Cynata Therapeutics | -38% | -35% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: Janine Rolfe, Non-Executive Director | 23 Jan 2023 |
| NEW ROLE: J. Airey, | 03 Jan 2023 |
| NEWS: Tagged in Cynata seals partnership for US stem cell therapy push | 30 Sep 2021 |
| NEW ROLE: S. Lipe, | 25 Aug 2021 |
| NEW ROLE: K. Kelly, | 25 Aug 2021 |
| NEW ROLE: P. Wotton, | 25 Aug 2021 |
| NEW ROLE: Ian Dixon, Co-Founder | 20 Jan 2021 |
| NEW ROLE: S Lipe, Vice President, Alliance Management ... | 24 Nov 2020 |
| NEW ROLE: K Kelly, Chief Operating Officer | 24 Nov 2020 |
